Cargando…
CRIMALDDI: platform technologies and novel anti-malarial drug targets
The Coordination, Rationalization, and Integration of antiMALarial drug Discovery & Development Initiatives (CRIMALDDI) Consortium, funded by the EU Framework Seven Programme, has attempted, through a series of interactive and facilitated workshops, to develop priorities for research to expedite...
Autores principales: | Vial, Henri, Taramelli, Donatella, Boulton, Ian C, Ward, Steve A, Doerig, Christian, Chibale, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827883/ https://www.ncbi.nlm.nih.gov/pubmed/24498961 http://dx.doi.org/10.1186/1475-2875-12-396 |
Ejemplares similares
-
CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
por: Boulton, Ian C, et al.
Publicado: (2010) -
CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs
por: Ward, Steve A, et al.
Publicado: (2013) -
Re-orienting anti-malarial drug development to better serve pregnant women
por: El Gaaloul, Myriam, et al.
Publicado: (2022) -
How can natural products serve as a viable source of lead compounds for the development of new/novel anti-malarials?
por: Guantai, Eric, et al.
Publicado: (2011) -
Two successful decades of Swiss collaborations to develop new anti-malarials
por: Hooft van Huijsduijnen, Rob, et al.
Publicado: (2019)